Xembify

Xembify is a human normal immunoglobulin solution for subcutaneous use, providing passive immunity support. It is derived from plasma and used for immune deficiency conditions. This product is manufactured by Instituto Grifols, S.A. and is available in the EU.

Xembify is used to treat primary immunodeficiency diseases in adults and children. It provides antibodies to help strengthen the immune system. This medication is also used for immune thrombocytopenia and other conditions requiring immunoglobulin therapy. It supports patients with low antibody levels.

Xembify works by supplying antibodies that the body needs to fight infections. Patients may experience improved resistance to common illnesses after regular use. The effects are gradual and depend on consistent administration. Some users report fewer infections over time.

Store Xembify in a refrigerator between 2°C and 8°C (36°F and 46°F). Do not freeze or shake the vial. Keep the product in its original packaging to protect it from light. Always check the expiration date before use. Discard any unused portion properly.

Xembify may interact with live vaccines, reducing their effectiveness. Avoid receiving live vaccines shortly before or after treatment. Inform healthcare providers about all medications and supplements in use. No specific interactions with alcohol or common foods have been widely reported.